The former executive director of the Greater Altoona Career and Technology Center was handed a mitigated sentence of five ...

The global Live Cell RNA Detection Market is set for robust expansion, with valuation projected to rise from USD 3.4 billion ...

Dawnzera is the first and only RNA-targeted prophylactic therapy to be approved for hereditary angioedema in adults and ...

A new study suggests an enzyme unique to Homo sapiens may have made us more competitive water seekers than our closest ...

According to the Cleveland Clinic, an American nonprofit academic medical centre, an mRNA vaccine trains your body to fight ...

Dawnzera is the first and so far only RNA-targeting therapy approved as a prophylactic treatment for hereditary angioedema ...

Over the last few years, scientists and entrepreneurs have flocked to developing medicines that target RNA, the genetic ...

Merck KGaA agreed to a deal with RNA biotech Skyhawk Therapeutics that could top out at $2 billion. Roche’s Genentech terminated a cell therapy partnership with Adaptive Biotechnologies, ending what ...